| The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial ME Nassif, SL Windsor, BA Borlaug, DW Kitzman, SJ Shah, F Tang, ... Nature medicine 27 (11), 1954-1960, 2021 | 415 | 2021 |
| Dapagliflozin effects on biomarkers, symptoms, and functional status in patients with heart failure with reduced ejection fraction: the DEFINE-HF trial ME Nassif, SL Windsor, F Tang, Y Khariton, M Husain, SE Inzucchi, ... Circulation 140 (18), 1463-1476, 2019 | 383 | 2019 |
| Association of Serial Kansas City Cardiomyopathy Questionnaire Assessments With Death and Hospitalization in Patients With Heart Failure With Preserved and Reduced Ejection … SJA Pokharel Y, Khariton Y, Tang Y, Nassif ME, Chan PS, Arnold SV, Jones PG JAMA: Cardiology, 2017 | 151 | 2017 |
| Target doses of heart failure medical therapy and blood pressure: insights from the CHAMP-HF registry PA Peri-Okonny, X Mi, Y Khariton, KK Patel, L Thomas, GC Fonarow, ... JACC: Heart Failure 7 (4), 350-358, 2019 | 96 | 2019 |
| Health status disparities by sex, race/ethnicity, and socioeconomic status in outpatients with heart failure Y Khariton, ME Nassif, L Thomas, GC Fonarow, X Mi, AD DeVore, C Duffy, ... JACC: Heart Failure 6 (6), 465-473, 2018 | 93 | 2018 |
| Association between sacubitril/valsartan initiation and health status outcomes in heart failure with reduced ejection fraction Y Khariton, GC Fonarow, SV Arnold, A Hellkamp, ME Nassif, PP Sharma, ... JACC: heart failure 7 (11), 933-941, 2019 | 56 | 2019 |
| Vaccination trends in patients with heart failure: Insights from get with the guidelines–heart failure AS Bhatt, L Liang, AD DeVore, GC Fonarow, SD Solomon, O Vardeny, ... JACC: Heart Failure 6 (10), 844-855, 2018 | 48 | 2018 |
| Impact of telemonitoring on health status NM Jayaram, Y Khariton, HM Krumholz, SI Chaudhry, J Mattera, F Tang, ... Circulation: Cardiovascular Quality and Outcomes 10 (12), e004148, 2017 | 39 | 2017 |
| Association between prompt defibrillation and epinephrine treatment with long-term survival after in-hospital cardiac arrest KK Patel, JA Spertus, Y Khariton, Y Tang, LH Curtis, PS Chan, PS Chan, ... Circulation 137 (19), 2041-2051, 2018 | 36 | 2018 |
| Association of changes in heart failure treatment with patients’ health status: real-world evidence from CHAMP-HF M Thomas, Y Khariton, GC Fonarow, SV Arnold, L Hill, ME Nassif, ... JACC: Heart Failure 7 (7), 615-625, 2019 | 26 | 2019 |
| Impact of transesophageal echocardiography on management in patients with suspected cardioembolic stroke Y Khariton, JA House, L Comer, TR Coggins, A Magalski, DG Skolnick, ... The American Journal of Cardiology 114 (12), 1912-1916, 2014 | 21 | 2014 |
| Health status variation across practices in outpatients with heart failure: insights from the CHAMP-HF (Change the Management of Patients With Heart Failure) Registry Y Khariton, AF Hernandez, GC Fonarow, PP Sharma, CI Duffy, L Thomas, ... Circulation: Cardiovascular Quality and Outcomes 11 (4), e004668, 2018 | 19 | 2018 |
| Health status benefits of successful chronic total occlusion revascularization across the spectrum of left ventricular function: insights from the OPEN-CTO registry Y Khariton, S Airhart, AC Salisbury, JA Spertus, KL Gosch, JA Grantham, ... JACC: Cardiovascular Interventions 11 (22), 2276-2283, 2018 | 18 | 2018 |
| Dapagliflozin effects on lung fluid volumes in patients with heart failure and reduced ejection fraction: results from the DEFINE‐HF trial ME Nassif, SL Windsor, F Tang, M Husain, SE Inzucchi, DK McGuire, ... Diabetes, Obesity and Metabolism 23 (6), 1426-1430, 2021 | 17 | 2021 |
| ’s Get With the Guidelines–Resuscitation Investigators. Association between prompt defibrillation and epinephrine treatment with long-term survival after in-hospital cardiac arrest KK Patel, JA Spertus, Y Khariton, Y Tang, LH Curtis, PS Chan Circulation 137 (19), 2041-2051, 2018 | 10 | 2018 |
| Guideline‐directed statin intensification in patients with new or worsening symptoms of peripheral artery disease Y Khariton, KK Patel, PS Chan, Y Pokharel, J Wang, JA Spertus, ... Clinical Cardiology 41 (11), 1414-1422, 2018 | 9 | 2018 |
| Systemizing the evaluation of acute heart failure in the emergency department: a quality improvement initiative V Hejjaji, A Scholes, K Kennedy, B Sperry, Y Khariton, E Dean, DS Lee, ... Circulation: Cardiovascular Quality and Outcomes 13 (11), e006168, 2020 | 8 | 2020 |
| Association between sacubitril/valsartan initiation and real‐world health status trajectories over 18 months in heart failure with reduced ejection fraction M Thomas, Y Khariton, GC Fonarow, SV Arnold, L Hill, ME Nassif, ... ESC heart failure 8 (4), 2670-2678, 2021 | 6 | 2021 |
| Effects of dapagliflozin on biomarkers, symptoms and functional status in patients with heart failure with reduced ejection fraction with and without diabetes-the Define-HF trial M Kosiborod, M Nassif, S Windsor, F Tang, Y Khariton, B Austin, ... Journal of Cardiac Failure 25 (11), 937-938, 2019 | 6 | 2019 |
| Association between change in ambulatory hemodynamic pressures and symptoms of heart failure ME Nassif, JA Spertus, F Tang, SL Windsor, P Jones, M Thomas, ... Circulation: Heart Failure 14 (11), e008446, 2021 | 4 | 2021 |
Michael NassifSaint Lukes Mid America Heart Institute在 saint-lukes.org 的电子邮件经过验证
Michael NassifSaint Lukes Mid America Heart Institute在 saint-lukes.org 的电子邮件经过验证
Yashashwi PokharelWake Forest University在 wakehealth.edu 的电子邮件经过验证
